1. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022) Authors: Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022) Authors: Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan; Aboo, Nazimuddin; ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. (April 2023) Authors: Feagan, Brian G; Sands, Bruce E; Sandborn, William J; Germinaro, Matthew; Vetter, Marion; Shao, Jie; Sheng, Shihong; Johanns, Jewel; Panés, Julián; Tkachev, Alexander; Kalimullina, Dilara; Petryka, Robert; Osipenko, Marina; Tsarynna, Nataliia; Bilianskyi, Leonid; Kleczkowski, Dariusz; Yurkiv, And... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 4(2023) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study. Issue 7 (24th August 2021) Authors: D'Haens, Geert R; Reinisch, Walter; Lee, Scott D; Tarabar, Dino; Louis, Edouard; Kłopocka, Maria; Klaus, Jochen; Schreiber, Stefan; Il Park, Dong; Hébuterne, Xavier; Nagy, Peter; Cataldi, Fabio; Martin, Steven W; Nayak, Satyaprakash; Banerjee, Anindita; Gorelick, Kenneth J; Sandborn, William J Journal: Inflammatory bowel diseases Issue: Volume 28:Issue 7(2022) Page Start: 1034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P037 LONG-TERM SAFETY, EFFICACY AND PHARMACOKINETICS OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) MONOCLONAL ANTIBODY SHP647 IN CROHN'S DISEASE: THE OPERA II STUDY. (7th February 2019) Authors: D'Haens, Geert; Reinisch, Walter; Lee, Scott D; Tarabar, Dino; Louis, Edouard; Klopocka, Maria; Klaus, Jochen; Schreiber, Stefan; Park, Dong-Il; Hébuterne, Xavier; Cataldi, Fabio; Martin, Steven W; Nayak, Satyaprakash; Banerjee, Anindita; Gorelick, Kenneth J; Sandborn, William J Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study. Issue 10 (5th October 2017) Authors: Sandborn, William J; Lee, Scott D; Tarabar, Dino; Louis, Edouard; Klopocka, Maria; Klaus, Jochen; Reinisch, Walter; Hébuterne, Xavier; Park, Dong-Il; Schreiber, Stefan; Nayak, Satyaprakash; Ahmad, Alaa; Banerjee, Anindita; Brown, Lisa S; Cataldi, Fabio; Gorelick, Kenneth J; Cheng, John B; Hassan-... Journal: Gut Issue: Volume 67:Issue 10(2018) Page Start: 1824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review. (October 2020) Authors: Terjung, Birgit; Schmelz, Renate; Ehehalt, Robert; Klaus, Jochen; Knop, Jana; Schwind, Sabine; Wilke, Thomas; Stallmach, Andreas Journal: Therapeutic advances in gastroenterology Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review. (October 2020) Authors: Terjung, Birgit; Schmelz, Renate; Ehehalt, Robert; Klaus, Jochen; Knop, Jana; Schwind, Sabine; Wilke, Thomas; Stallmach, Andreas Journal: Therapeutic advances in gastroenterology Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗